Bamifylline
Bamifylline is a bronchodilator medication used to manage asthma and other respiratory conditions involving reversible airway narrowing and bronchospasm. It belongs to the xanthine derivative class and acts primarily as a selective adenosine A1 receptor antagonist, helping relax airway smooth muscles and improve airflow. Bamifylline is available mainly as oral tablets, with dosage determined by the patient’s condition and local prescribing guidance. Possible side effects include headache, stomach discomfort, nausea, mild tremors, and allergic skin reactions. Caution is required in patients with heart disease, high blood pressure, hyperthyroidism, or kidney or liver impairment. It is intended for prescribed respiratory management and should not be relied upon for immediate relief of a sudden asthma attack.
Bamifylline was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Bamifylline, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Bamifylline from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Bamifylline, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
